Acceder

Publicaciones - FARMACOCINETICA CLINICA Y FARMACOTERAPIA APLICADA

Cargando...
Diaz LS, Navalon CI, Espin RG, Nicolas de Prado I, Redondo LR. Impact of proactive of infliximab monitoring using the Bayesian approach in the maintenance phase in patients with inflammatory bowel disease. Gastroenterol Hepatol. 2022 Nov 15:S0210-5705(22)00265-5. doi: 10.1016/j.gastrohep.2022.10.019. Online ahead of print. No abstract available. English, Spanish. PubMed PMID: 36400260.
AÑO: 2022; IF: 1.9
36400260
Serrano-Diaz L, Iniesta-Navalon C, Gomez-Espin R, Nicolas-de Prado I, Bernal-Morell E, Rentero-Redondo L. Impact of proactive therapeutic drug monitoring of infliximab during the induction phase in IBD patients. A Bayesian approach. Rev Esp Enferm Dig. 2022 Dec 23. doi: 10.17235/reed.2022.8781/2022. Online ahead of print. PubMed PMID: 36562529.
AÑO: 2022; IF: 2.0
36562529
Gómez Espín R, Nicolás De Prado I, Gil Candel M, González Carrión M, Rentero Redondo L, Iniesta Navalón C. Association between ustekinumab trough concentrations and biochemical outcomes in patients with Crohn's disease. A real life study. Rev Esp Enferm Dig. 2021 Feb;113(2):110-115. doi: 10.17235/reed.2020.7124/2020. PubMed PMID: 33213170.
AÑO: 2021; IF: 2.389
33213170
Iniesta Navalón C, Gil Candel M, Salar Valverde I, Nicolás de Prado I, Gómez Espín R, Rentero Redondo L. Biosimilar infliximab CPT-13 for inflammatory bowel disease in a real clinical setting: pharmacokinetic outcomes, immunogenicity, and drug survival. Rev Esp Enferm Dig. 2021 Nov;113(11):770-775. doi: 10.17235/reed.2021.7638/2020. PubMed PMID: 33486961.
AÑO: 2021; IF: 2.389
33486961
Gil Candel M, Gascón Cánovas JJ, Gómez Espín R, Nicolás de Prado I, Rentero Redondo L, Urbieta Sanz E, Iniesta Navalón C. Usefulness of population pharmacokinetics to optimize the dosage regimen of infliximab in inflammatory bowel disease patients. Rev Esp Enferm Dig. 2020 Aug;112(8):590-597. doi: 10.17235/reed.2020.6857/2020. PubMed PMID: 32686429.
AÑO: 2020; IF: 2.086
32686429
Siguiente >
IMIB-Arrixaca

Instituto de Investigación Sanitaria Acreditado

ISCII

FARMACOCINETICA CLINICA Y FARMACOTERAPIA APLICADA